In vitro determination of the antibiotic susceptibility of biofilm-forming Pseudomonas aeruginosa and Staphylococcus aureus: Possible role of proteolytic activity and membrane lipopolysaccharide

Infection and Drug Resistance

Volumn 6, Issue , 2013, Pages 27-32

  Masadeh, Majed M ^a   Mhaidat, Nizar M ^a   Alzoubi, Karem H ^a   Hussein, Emad I ^b   Al Trad, Esra'a I ^a  

^a JORDAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Jordan)

^b YARMOUK UNIVERSITY   (Jordan)

Author keywords

Biofilm; Lipopolysaccharide; Proteolytic activity; Pseudomonas aeruginosa; Staphylococcus aureus

Indexed keywords

AMIKACIN; AMOXICILLIN; BACTERIUM LIPOPOLYSACCHARIDE; CEFACLOR; CEFTAZIDIME; CIPROFLOXACIN; COTRIMOXAZOLE; LIPID A; O ANTIGEN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIAL SURVIVAL; BACTERIOPLANKTON; BACTERIUM CULTURE; BIOFILM; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME ACTIVITY; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN DEGRADATION; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

EID: 84875001050     PISSN: 11786973     EISSN: None     Source Type: Journal    
DOI: 10.2147/IDR.S41501     Document Type: Article

References (38)

1. Johnjulio W, Fuge LH, Kad M, Post C. Introduction to biofilms in family medicine. South Med J. 2012;105(1):24-29.
2. Wolcott R, Dowd S. The role of biofilms: are we hitting the right target? Plast Reconstr Surg. 2011;127(Suppl 1):28S-35S.
3. Brooks JL, Jefferson KK. Staphylococcal biofilms: quest for the magic bullet. Adv Appl Microbiol. 2012;81:63-87.
4. Aparna MS, Yadav S. Biofilms: microbes and disease. Braz J Infect Dis. 2008;12(6):526-530.
5. Lynch AS, Robertson GT. Bacterial and fungal biofilm infections. Annu Rev Med. 2008;59:415-428.
6. Wang X, Wood TK. Toxin-antitoxin systems influence biofilm and persister cell formation and the general stress response. Appl Environ Microbiol. 2011;77(16):5577-5583.
7. Wilson SK, Costerton JW. Biofilm and penile prosthesis infections in the era of coated implants: a review. J Sex Med. 2012;9(1):44-53.
8. Huang R, Li M, Gregory RL. Bacterial interactions in dental biofilm. Virulence. 2011;2(5):435-444.
9. Vlassova N, Han A, Zenilman JM, James G, Lazarus GS. New horizons for cutaneous microbiology: the role of biofilms in dermatological disease. Br J Dermatol. 2011;165(4):751-759.
10. Davey ME, O'Toole GA. Microbial biofilms: from ecology to molecular genetics. Microbiol Mol Biol Rev. 2000;64(4):847-867.
11. Kyd JM, McGrath J, Krishnamurthy A. Mechanisms of bacterial resistance to antibiotics in infections of COPD patients. Curr Drug Targets. 2011;12(4):521-530.
12. Jensen PO, Givskov M, Bjarnsholt T, Moser C. The immune system vs Pseudomonas aeruginosa biofilms. FEMS Immunol Med Microbiol. 2010;59(3):292-305.
13. Sawhney R, Berry V. Bacterial biofilm formation, pathogenicity, diagnostics and control: An overview. Indian J Med Sci. 2009;63(7): 313-321.
14. Gaynor M, Mankin AS. Macrolide antibiotics: binding site, mechanism of action, resistance. Curr Top Med Chem. 2003;3(9):949-961.
15. Canton R, Morosini MI. Emergence and spread of antibiotic resistance following exposure to antibiotics. FEMS Microbiol Rev. 2011;35(5): 977-991.
16. Zhang L, Mah TF. Involvement of a novel efflux system in biofilmspecific resistance to antibiotics. J Bacteriol. 2008;190(13):4447-4452.
17. Cernohorska L, Votava M. Antibiotic synergy against biofilm-forming Pseudomonas aeruginosa. Folia Microbiol (Praha). 2008;53(1): 57-60.
18. Christensen GD, Simpson WA, Younger JJ, et al. Adherence of coagulase-negative staphylococci to plastic tissue culture plates: a quantitative model for the adherence of staphylococci to medical devices. J Clin Microbiol. 1985;22(6):996-1006.
19. Clinical and Laboratory Standards Institute (CLSI). Methods for dilution antimicrobial susceptibility test for bacteria that grow aerobically. Approved standard. ninth edition. Villanova, PA: 2012.
20. Schmidtchen A, Wolff H, Hansson C. Differential proteinase expression by Pseudomonas aeruginosa derived from chronic leg ulcers. Acta Derm Venereol. 2001;81(6):406-409.
21. Okamoto T, Akaike T, Suga M, et al. Activation of human matrix metalloproteinases by various bacterial proteinases. J Biol Chem. 1997;272(9):6059-6066.
22. Duan ZG, Yan XJ, He XZ, et al. Extraction and protein component analysis of venom from the dissected venom glands of Latrodectus tredecimguttatus. Comp Biochem Physiol B Biochem Mol Biol. 2006;145(3-4):350-357.
23. Tsai CM, Frasch CE. A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels. Anal Biochem. 1982; 119(1):115-119.
24. Hoekstra JL, de Neeling AJ, van Klingeren V, Stobberingh EE, van Boven CP. Resistant strains of Pseudomonas aeruginosa isolated after exposure to several beta-lactam antibiotics. Eur J Clin Microbiol. 1987;6(1):22-27.
25. Cos P, Tote K, Horemans T, Maes L. Biofilms: an extra hurdle for effective antimicrobial therapy. Curr Pharm Des. 2010;16(20):2279-2295.
26. Khan W, Bernier SP, Kuchma SL, Hammond JH, Hasan F, O'Toole GA. Aminoglycoside resistance of Pseudomonas aeruginosa biofilms modulated by extracellular polysaccharide. Int Microbiol. 2010;13(4):207-212.
27. Hoiby N, Bjarnsholt T, Givskov M, Molin S, Ciofu O. Antibiotic resistance of bacterial biofilms. Int J Antimicrob Agents. 2010;35(4): 322-332.
28. Hoiby N, Ciofu O, Johansen HK, et al. The clinical impact of bacterial biofilms. Int J Oral Sci. 2011;3(2):55-65.
29. Simoes M. Antimicrobial strategies effective against infectious bacterial biofilms. Curr Med Chem. 2011;18(14):2129-2145.
30. Fluit AC, Schmitz FJ. Bacterial resistance in urinary tract infections: how to stem the tide. Expert Opin Pharmacother. 2001;2(5):813-818.
31. Rupp ME, Hamer KE. Effect of subinhibitory concentrations of vancomycin, cefazolin, ofloxacin, L-ofloxacin and D-ofloxacin on adherence to intravascular catheters and biofilm formation by Staphylococcus epidermidis. J Antimicrob Chemother. 1998;41(2): 155-161.
32. Hatt JK, Rather PN. Role of bacterial biofilms in urinary tract infections. Curr Top Microbiol Immunol. 2008;322:163-192.
33. Frei E, Hodgkiss-Harlow K, Rossi PJ, Edmiston CE Jr, Bandyk DF. Microbial pathogenesis of bacterial biofilms: a causative factor of vascular surgical site infection. Vasc Endovascular Surg. 2011;45(8):688-696.
34. Fernandez L, Breidenstein EB, Song D, Hancock RE. Role of intracellular proteases in the antibiotic resistance, motility, and biofilm formation of Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2012;56(2):1128-1132.
35. Breidenstein EB, de la Fuente-Nunez C, Hancock RE. Pseudomonas aeruginosa: all roads lead to resistance. Trends Microbiol. 2011;19(8): 419-426.
36. Anuntagool N, Wuthiekanun V, White NJ, et al. Lipopolysaccharide heterogeneity among Burkholderia pseudomallei from different geographic and clinical origins. Am J Trop Med Hyg. 2006;74(3): 348-352.
37. Coulon C, Vinogradov E, Filloux A, Sadovskaya I. Chemical analysis of cellular and extracellular carbohydrates of a biofilm-forming strain Pseudomonas aeruginosa PA14. PLoS One. 2010;5(12):e14220.
38. Sawasdidoln C, Taweechaisupapong S, Sermswan RW, Tattawasart U, Tungpradabkul S, Wongratanacheewin S. Growing Burkholderia pseudomallei in biofilm stimulating conditions significantly induces antimicrobial resistance. PLoS One. 2010;5(2):e9196.